Related Experiment Video
Updated: Sep 25, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Membranous lipodystrophy (Nasu-Hakola disease) presenting an unusually benign clinical course
Kumiko Haruta1, Shunji Matsunaga, Hiroshi Ito
1Department of Orthopaedic Surgery, Faculty of Medicine, Kagoshima University 8-35-1, Sakuragaoka, Kagoshima 890-8520, Japan.
Abstract:
Membranous lipodystrophy is known as Nasu-Hakola disease. The main symptoms of membranous lipodystrophy are those of a progressive presenile dementia due to sclerosing leukoencephalopathy with skeletal polycystic lesions. There is no report detailing long-term follow-up of patients with membranous lipodystrophy. We present a 56-year-old woman with this disease who has not manifested any typical neuropsychiatric symptoms during the 16-year follow-up, and thus has had an unusually benign clinical course. The patient underwent curettage and bone grafts. Periodic examinations have been continued for 16 years from discharge. No recurrence of lesions or occurrence of new cystic lesions has been noted. Computerized tomography and magnetic resonance imaging of the brain revealed none of the abnormal change which are reported in this disease. Our findings suggest that some patients with this disease may be fortunate enough to follow a relatively benign clinical course.
Insights
Nasu-Hakola disease, or membranous lipodystrophy, typically causes dementia. This case study highlights a patient with an unusually benign 16-year clinical course, showing no typical neuropsychiatric symptoms.
Area of Science:
- Neurology
- Genetics
- Radiology
Background:
- Membranous lipodystrophy, also known as Nasu-Hakola disease, is a rare genetic disorder.
- Characterized by progressive presenile dementia, sclerosing leukoencephalopathy, and skeletal polycystic lesions.
- Limited long-term follow-up data exists for patients with this condition.
Observation:
- A 56-year-old female patient with membranous lipodystrophy was followed for 16 years post-treatment.
- The patient underwent curettage and bone grafts for skeletal lesions.
- Periodic examinations included imaging to monitor for disease progression.
Findings:
- The patient exhibited an unusually benign clinical course, lacking typical neuropsychiatric symptoms.
- No recurrence of skeletal lesions or development of new cystic lesions was observed over 16 years.
- Brain imaging (CT and MRI) showed no abnormalities typically associated with Nasu-Hakola disease.
Implications:
- Suggests that some individuals with membranous lipodystrophy may experience a less severe clinical trajectory.
- Highlights the importance of long-term monitoring in rare genetic disorders.
- Contributes to understanding the phenotypic variability of Nasu-Hakola disease.
Related Concept Videos
Lysosomal Hydrolases
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cirrhosis I: Introduction

